You are here: Industry Insights > Stem Cell

News List

Blocking two proteins could improve stem cell transplants for blood cancers fiercebiotech
September 11, 2017
Transplants of hematopoietic, or blood-forming, stem cells can be used to treat blood cancers or cancers of the immune system.
TissueGene awarded $750,000 Maryland Stem Cell Grant for Invossa clinical study biospectrumasia
July 04, 2017
The grant award will be used by TissueGene to fund a component of a clinical study at a Maryland location for its US Phase III clinical trial for Invossa.
Longeveron Announces Phase 1 Safety, Efficacy Results for Allogeneic Stem Cell Treatment americanpharmaceuticalreview
May 17, 2017
Longeveron announced publication of Phase 1 safety, tolerability and efficacy data of its proprietary allogeneic mesenchymal stem cell (MSC) product in patients with Aging Frailty. The results were published on April 21st online in the Journals of Geronto
BioLineRx Initiates Phase 3 Study with BL-8040 as Novel Stem Cell Mobilization Treatment americanpharmaceuticalreview
May 04, 2017
BioLineRx announced it met with the U.S. Food and Drug Administration (FDA) and gained clarity on the development program and the design of a Phase 3 pivotal study for BL-8040 as a novel stem cell mobilization treatment for autologous bone-marrow transpla
Plasticell signs stem cell research collaborations with leading Singapore academic institutions pharmasia
April 06, 2017
Plasticell signed with the Agency for Science, Technology and Research and Nanyang Technological University to progress therapeutic stem cell pipeline.
TiGenix announces success of novel heart attack stem cell trial pharmafile
March 14, 2017
Belgium’s TiGenix has announced the success of its top-line Phase 2/3 study investigating the effects of donor-derived expanded cardiac stem cells (AlloCSCs) in the treatment of acute myocardial infarction (AMI)
Health Canada approves REVLIMID plus dexamethasone as a first-line treatment for patients newly diag firstwordpharma
January 25, 2017
Celgene Inc. announced today that Health Canada has expanded the indication for REVLIMID® (lenalidomide capsules), in multiple myeloma.
First of its kind cancer stem cell research unlocks clues to treatment resistance firstwordpharma
January 22, 2017
Study data published in the journal Oncotarget suggest that a molecule lost from cancer stem cells, called miR-17, is important in driving oesophageal tumour resistance to radiotherapy, ScienceDaily reported.

Previous page 1 2 3 Next page